Nevro Corp.

NYSE:NVRO

3.79 (USD) • At close December 20, 2024
Bedrijfsnaam Nevro Corp.
Symbool NVRO
Munteenheid USD
Prijs 3.79
Beurswaarde 142,017,364
Dividendpercentage 0%
52-weken bereik 3.52 - 22.525
Industrie Medical Devices
Sector Healthcare
CEO Mr. Kevin R. Thornal
Website https://www.nevro.com

An error occurred while fetching data.

Over Nevro Corp.

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems.

Vergelijkbare Aandelen

U.S. Physical Therapy, Inc. logo

U.S. Physical Therapy, Inc.

USPH

91.31 USD

Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc.

MD

14.09 USD

Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc.

EBS

8.1 USD

Taro Pharmaceutical Industries Ltd. logo

Taro Pharmaceutical Industries Ltd.

TARO

42.975 USD

Arcus Biosciences, Inc. logo

Arcus Biosciences, Inc.

RCUS

15.5 USD

Avanos Medical, Inc. logo

Avanos Medical, Inc.

AVNS

16.08 USD

Paragon 28, Inc. logo

Paragon 28, Inc.

FNA

10.03 USD

Glaukos Corporation logo

Glaukos Corporation

GKOS

150.88 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)